BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27431077)

  • 21. Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
    Myoken Y; Kyo T; Sugata T; Murayama SY; Mikami Y
    Haematologica; 2006 Feb; 91(2):287-8. PubMed ID: 16461328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A clinical evaluation of fluconazole in deep seated fungal infections associated with hematological disorders].
    Murakami S; Misago M; Tohnai S; Nakanishi M; Ogawa R; Wake A; Nagata K; Mori N; Tsukada J; Nakata K; Oda S; Morimoto I; Eto S; Izumi Y; Sawada H; Yamasaki Y; Yamano Y; Ohmori F; Ohkuma K; Ohnishi Y; Yamamura M; Asano Y; Tanaka H; Ikeda K; Oda E
    Jpn J Antibiot; 1996 Jan; 49(1):95-105. PubMed ID: 8851308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of itraconazole for systemic fungal infections complicated with hematological malignancies--multicenter cooperative study. West-Japan Systemic Fungal Infection Study Group].
    Shiku H; Horiuchi A; Kuramoto A; Harada M; Niho Y
    Kansenshogaku Zasshi; 1998 Nov; 72(11):1208-18. PubMed ID: 9884508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
    Pagano L; Caira M; Candoni A; Offidani M; Fianchi L; Martino B; Pastore D; Picardi M; Bonini A; Chierichini A; Fanci R; Caramatti C; Invernizzi R; Mattei D; Mitra ME; Melillo L; Aversa F; Van Lint MT; Falcucci P; Valentini CG; Girmenia C; Nosari A
    Haematologica; 2006 Aug; 91(8):1068-75. PubMed ID: 16885047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients.
    Krcméry V; Koza I; Hornikova M; Fuchsberger P; Spanik S; Mardiak J; Sufliarsky J; Blahova M; Savko V; Migom C
    Chemotherapy; 1991; 37(5):343-5. PubMed ID: 1804594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylaxis and treatment of fungal infections associated with haematological malignancies.
    Ascioglu S; de Pauw BE; Meis JF
    Int J Antimicrob Agents; 2000 Aug; 15(3):159-68. PubMed ID: 10926437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical efficacy of fluconazole against fungal infections in hematological diseases].
    Morioka E; Asahara F; Nagano M; Kawasaki C; Yoshida T; Uchida T; Nakashima H; Suzumiya J; Kimura N; Hisano S; Okumura M
    Jpn J Antibiot; 1996 Apr; 49(4):399-402. PubMed ID: 8786630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.
    Huijgens PC; Simoons-Smit AM; van Loenen AC; Prooy E; van Tinteren H; Ossenkoppele GJ; Jonkhoff AR
    J Clin Pathol; 1999 May; 52(5):376-80. PubMed ID: 10560360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection of systemic candidiasis in the whole blood of patients with hematologic malignancies.
    Badiee P; Kordbacheh P; Alborzi A; Zakernia M; Haddadi P
    Jpn J Infect Dis; 2009 Jan; 62(1):1-5. PubMed ID: 19168950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of fluconazole].
    Oka S; Tokitsu M; Mori H; Nakata H; Goto M; Goto H; Shimada K
    Jpn J Antibiot; 1989 Jan; 42(1):31-9. PubMed ID: 2540365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
    Feng AM; Wei JY; Yu WJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):473-5. PubMed ID: 22213868
    [No Abstract]   [Full Text] [Related]  

  • 32. Systemic fungal infections in patients with hematologic malignancies: indications and limitations of the antifungal armamentarium.
    Böhme A; Karthaus M
    Chemotherapy; 1999; 45(5):315-24. PubMed ID: 10473919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial.
    Timmers GJ; Zweegman S; Simoons-Smit AM; van Loenen AC; Touw D; Huijgens PC
    Bone Marrow Transplant; 2000 Apr; 25(8):879-84. PubMed ID: 10808210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prior invasive fungal infection is not a contraindication for subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies.
    Wang JT; Yao M; Tang JL; Chang SC; Hung CC
    J Clin Oncol; 2001 Oct; 19(19):4000-1. PubMed ID: 11579127
    [No Abstract]   [Full Text] [Related]  

  • 35. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
    Prentice AG; Glasmacher A; Djulbegovic B
    Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845
    [No Abstract]   [Full Text] [Related]  

  • 36. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
    Isaacs D
    Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of single-dose and 7-day fluconazole treatment of fungal esophagitis in alcoholic liver disease.
    Péter Z; Horváth Z; Makara M; Telegdy L; Zala J; Zágoni T
    Z Gastroenterol; 1996 Jun; 34(6):361-4. PubMed ID: 8767824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Characteristics and Manifestations of Fungal Esophagitis: A Single-Center Experience in South China.
    Zhan SK; Wu XQ; Zheng FP
    Gastroenterol Res Pract; 2021; 2021():8869494. PubMed ID: 33531895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India.
    Dewan E; Biswas D; Kakati B; Verma SK; Kotwal A; Oberoi A
    Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):99-105. PubMed ID: 26173033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.